5637 and T24 cells were seeded in 6‐well plates with RPMI‐1640 medium supplemented with 10% FBS. When cells reached confluence, they were washed with 1× PBS and cultured in serum‐free medium (1 ml/well). After an incubation for 4–6 h, the supernatant was replaced with fresh RPMI‐1640 medium containing 25% FBS and the STAT3 inhibitor Stattic (2 or 2.5 μM; #9983‐44‐9, MedChemExpress, NJ, USA). After 24 h, the medium was replaced with fresh RPMI‐1640 medium containing 10% FBS, and then the supernatant was collected after 24 h. After the cells were cultured with recombinant human IL8 (1 × 10−4 g/L; Peprotech, CI6217, Princeton Business Park, NJ, USA) and human antibody IL8 (5×10−4 g/L; Biotechne, MAB208‐SP, Minneapolis, MN, USA) for 24 h separately, they were switched to fresh RPMI‐1640 medium containing 10% FBS, and the supernatant was collected after 24 h.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.